Revenue
2021
2022
2023
2024
2025
Cardio Diagnostics Holdings, Inc. (CDIO)
Price$1.83Cached quote
Net income
2021
2022
2023
2024
2025
Free cash flow
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $14,825 | $34,890 | $17,065 | $950 | $901 |
| Research & development | $641,212 | $227,966 | $145,182 | $40,448 | $31,468 |
| Operating expenses | $6.5M | $8.4M | $7.3M | $4.5M | $621,349 |
| Operating income | −$6.5M | −$8.4M | −$7.2M | −$4.5M | −$620,448 |
| Operating margin | −43,737.46% | −23,977.86% | −42,440.43% | −478,784.32% | −68,862.15% |
| EBITDA | −$6.4M | −$8.3M | −$7.2M | −$4.5M | −$604,448 |
| EBITDA margin | −43,297.44% | −23,921.29% | −42,328.02% | −477,100.11% | −67,086.35% |
| Net income | −$6.5M | −$8.4M | −$8.4M | −$4.7M | −$620,448 |
| Net profit margin | −43,832.49% | −24,028.24% | −49,087.81% | −490,630.00% | −68,862.15% |
| Basic EPSper basic share | -$3.71 | -$9.35 | -$19.80 | -$45.30 | -$15.90 |
| Diluted EPSper diluted share | -$3.71 | -$9.35 | -$19.80 | -$45.30 | -$15.90 |
Owners
Reported shareholders
≈56.90%of listed shares
Philibert Robert1.68M shares · Sep 6, 2024
View holders
| Holder | % owned |
|---|---|
Philibert Robert | ≈56.90%1.68M shares |
Dogan Meeshanthini | ≈55.94%1.66M shares |
Dogan Timur | ≈6.67%197.31K shares |
RENAISSANCE TECHNOLOGIES LLC | 1.66%49.2K shares |
BlackRock, Inc. | 1.17%34.71K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.89%26.23K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 0.68%20.16K shares |
CITADEL ADVISORS LLC | 0.64%19.07K shares |
XTX Topco Ltd | 0.54%16.09K shares |
JANE STREET GROUP, LLC | 0.40%11.93K shares |
STATE STREET CORP | 0.34%10.1K shares |
VANGUARD FIDUCIARY TRUST CO | 0.10%2.82K shares |
Tower Research Capital LLC (TRC) | 0.06%1.81K shares |
UBS Group AG | 0.02%656 shares |
WOLVERINE ASSET MANAGEMENT LLC | <0.01%104 shares |
MORGAN STANLEY | <0.01%100 shares |
OSAIC HOLDINGS, INC. | <0.01%16 shares |
SHP Wealth Management | <0.01%16 shares |
SBI Securities Co., Ltd. | <0.01%10 shares |
WELLS FARGO & COMPANY/MN | <0.01%2 shares |
Percentages use 2.96M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Reported positions exceed 100% in total, so the circle shows the selected holder only.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Sep 6, 2024Form 4/A | Dogan TimurChief Technology Officer | BuyCommon Stock | 69.0K | $0.29 | $20.0K | 197.3K |
| Sep 6, 2024Form 4/A | Dogan MeeshanthiniChief Executive Officer | BuyCommon Stock | 69.0K | $0.29 | $20.0K | 1.66M |
| Sep 6, 2024Form 4/A | Dogan MeeshanthiniChief Executive Officer | BuyCommon Stock | 69.0K | $0.29 | $20.0K | 1.66M |
| Sep 6, 2024Form 4/A | Dogan TimurChief Technology Officer | BuyCommon Stock | 69.0K | $0.29 | $20.0K | 197.3K |
| Sep 6, 2024Form 4 | Philibert RobertChief Medical Officer | BuyCommon Stock · indirect | 7.5K | $0.28 | $2.1K | 1.68M |